LifeMD (LFMD) Cash from Investing Activities (2018 - 2025)

LifeMD has reported Cash from Investing Activities for 8 years, with the latest figure at $642774.0 in Q4 2025.

• For the quarter ending Q4 2025, Cash from Investing Activities rose 123.63% year-over-year to $642774.0; the trailing twelve-month figure through Dec 2025 stood at -$9.5 million (up 17.49% YoY), and the FY2025 full-year result was -$9.5 million, up 17.49% from the prior year.
• Cash from Investing Activities for Q4 2025 stood at $642774.0, up from -$3.6 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $642774.0 in Q4 2025, with the low at -$7.4 million in Q1 2022.
• Historically, Cash from Investing Activities has averaged -$2.4 million across 5 years, with a median of -$2.3 million in 2022.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities plunged 15000.67% — and 2025, when it soared 123.63%.
• LifeMD's Cash from Investing Activities stood at -$1.6 million in 2021, then slipped by 12.2% to -$1.8 million in 2022, then retreated by 25.16% to -$2.2 million in 2023, then decreased by 22.74% to -$2.7 million in 2024, then soared by 123.63% to $642774.0 in 2025.
• The last three Cash from Investing Activities figures came in at $642774.0 (Q4 2025), -$3.6 million (Q3 2025), and -$3.7 million (Q2 2025), per Business Quant data.